Welcome
The Office of Health Economics provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.
The OHE has an international reputation, for the quality and independence of its research, which is safeguarded through our Policy Board and Editorial Board.
OHE Compendium
Emma Hawe – Head of Statistics
The Essential Data Source for Understanding the UK Health Sector
The OHE Compendium of Health Statistics is a onestop statistical source specially designed for easy use by everyone interested in the UK health care sector and the NHS. It contains over 300 easy-to-read tables and charts accompanied by explanatory notes, source details and full commentary on a wide collection of topics related to UK health, health care and health spending. The Compendium is divided into four main sections: Demographics, including population, morbidity and mortality; UK health care expenditure and costs of the NHS; Hospital services; and Family health services. Information is updated annually and ranges from age structure, to detailed information such as death rates by cause, and NHS expenditure on pharmaceuticals.
Compiled independently by the Office of Health Economics, the Compendium of Health Statistics draws together data from numerous scattered sources. It also includes comparisons with other economically developed nations. The UK data are frequently broken down into England, Scotland, Northern Ireland and Wales, and many contain figures from as far back as the first full year of the data series NHS.
Publications
Three Challenges to Achieving Better Analysis for Better Decisions: Generalisability, Complexity and thresholds. Notes on a conference in honour of Bernie O’Brien
By A Towse and M Buxton
In June 2006 a conference entitled Better Analysis for Better Decisions: Bridging the Gap Between Economic Evaluation and Healthcare Decision-making was held at McMaster University in honour of the late Bernie O’Brien. Leading health economists presented reviews of the use of economic evaluation in the UK, Canada and USA …...
Consulting
Donor Investment Choices for Global Health: Modelling the value for money of investing in product development, public private partnerships as compared to other health care interventions